Related Experiment Video

Updated: Jun 14, 2026

Porous Silicon Microparticles for Delivery of siRNA Therapeutics
08:31

Porous Silicon Microparticles for Delivery of siRNA Therapeutics

Published on: January 15, 2015

Introduction of stearoyl moieties into a biocompatible cationic polyaspartamide derivative, PAsp(DET), with endosomal

Hyun Jin Kim1, Atsushi Ishii, Kanjiro Miyata

  • 1Department of Materials Engineering, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan.

Journal of Controlled Release : Official Journal of the Controlled Release Society
|April 3, 2010
PubMed

Insights

Researchers developed a modified polymer, stearoyl polyaspartamide (PAsp(DET)), for enhanced small interfering RNA (siRNA) delivery in cancer therapy. This hydrophobic modification improves complex stability and cellular uptake, leading to more effective gene silencing in pancreatic cancer cells.

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Cancer Therapeutics

Background:

  • Small interfering RNA (siRNA) holds promise for cancer therapy, but efficient and safe delivery remains a challenge.
  • Cationic polyaspartamide derivatives like poly{N-[N-(2-aminoethyl)-2-aminoethyl]aspartamide} (PAsp(DET)) show low cytotoxicity but struggle with unstable siRNA complex formation.
  • Existing delivery systems face hurdles in achieving effective gene silencing due to carrier toxicity and instability.

Purpose of the Study:

  • To enhance the siRNA delivery capabilities of polyaspartamide (PAsp(DET)) by introducing hydrophobic stearic acid moieties.
  • To investigate the impact of stearoyl modification on the stability and efficacy of PAsp(DET)/siRNA complexes.
  • To evaluate the in vitro gene knockdown efficiency of the modified delivery system in pancreatic cancer cells.

Main Methods:

  • Conjugation of stearic acid to the PAsp(DET) backbone at varying substitution degrees.
  • Characterization of the resulting stearoyl PAsp(DET)/siRNA complexes, assessing formation and stability.
  • In vitro assessment of gene silencing targeting BCL-2 and VEGF in human pancreatic adenocarcinoma (Panc-1) cells.

Main Results:

  • Stearoyl introduction significantly improved siRNA complex formation and stability compared to unmodified PAsp(DET).
  • The stearoyl PAsp(DET)/siRNA complexes demonstrated superior endogenous gene (BCL-2, VEGF) knockdown in Panc-1 cells.
  • Enhanced cellular internalization is suggested as a key factor for the improved gene silencing efficacy.

Conclusions:

  • Hydrophobic modification of PAsp(DET) with stearic acid creates a stable and effective siRNA delivery platform.
  • This approach overcomes the limitations of previous PAsp(DET) formulations for siRNA delivery.
  • The developed hydrophobic PAsp(DET)-mediated system shows potential for in vivo siRNA delivery in cancer treatment.

More Related Videos

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery09:09

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery

Published on: May 2, 2019

Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery08:53

Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery

Published on: April 16, 2019

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...